Tuomas Mirtti

RSS feed of this list

  1. Repeat multiparametric MRI in prostate cancer patients on active surveillance

    Eineluoto, J. T., Jarvinen, P., Kenttämies, A., Kilpeläinen, T. P., Vasarainen, H., Sandeman, K., Erickson, A., Mirtti, T. & Rannikko, A. 27 Dec 2017 In : PLoS One. 12, 12, 11 p., 0189272

    Research output: Scientific - peer-reviewArticle

  2. Feasibility of Prostate PAXgene Fixation for Molecular Research and Diagnostic Surgical Pathology Comparison of Matched Fresh Frozen, FFPE, and PFPE Tissues

    Högnäs, G., Kivinummi, K., Kallio, H. M. L., Hieta, R., Ruusuvuori, P., Koskenalho, A., Kesseli, J., Tammela, T. L. J., Riikonen, J., Ilvesaro, J., Kares, S., Hirvikoski, P. P., Laurila, M., Mirtti, T., Nykter, M., Kujala, P. M., Visakorpi, T., Tolonen, T. & Bova, G. S. Jan 2018 In : American Journal of Surgical Pathology. 42, 1, p. 103-115 13 p.

    Research output: Scientific - peer-reviewArticle

  3. Immunological tumor status may predict response to neoadjuvant chemotherapy and outcome after radical cystectomy in bladder cancer

    Tervahartiala, M., Taimen, P., Mirtti, T., Koskinen, I., Ecke, T., Jalkanen, S. & Bostrom, P. J. 4 Oct 2017 In : Scientific Reports. 7, 9 p., 12682

    Research output: Scientific - peer-reviewArticle

  4. A randomized trial of early detection of clinically significant prostate cancer (ProScreen): study design and rationale

    Auvinen, A., Rannikko, A., Taari, K., Kujala, P., Mirtti, T., Kenttamies, A., Rinta-Kiikka, I., Lehtimaki, T., Oksala, N., Pettersson, K. & Tammela, T. L. Jun 2017 In : European Journal of Epidemiology. 32, 6, p. 521-527 7 p.

    Research output: Scientific - peer-reviewArticle

  5. E-pub ahead of print
  6. Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data

    Guinney, J., Wang, T., Laajala, T. D., Winner, K. K., Bare, J. C., Neto, E. C., Khan, S. A., Peddinti, G., Airola, A., Pahikkala, T., Mirtti, T., Yu, T., Bot, B. M., Shen, L., Abdallah, K., Norman, T., Friend, S., Stolovitzky, G., Soule, H., Sweeney, C. J., Ryan, C. J., Scher, H. I., Sartor, O., Xie, Y., Aittokallio, T., Zhou, F. L., Costello, J. C. & Prostate Canc Challenge DREAM Comm Jan 2017 In : Lancet Oncology. 18, 1, p. 132-142 11 p.

    Research output: Scientific - peer-reviewArticle

  7. Eturauhassyövän diagnostiikka murroksessa

    Sandeman, K., Rannikko, A., Kenttämies, A. & Mirtti, T. 2016 In : Duodecim. 132, 24, p. 2351-2358 8 p.

    Research output: Scientific - peer-reviewArticle

  8. Loss of PTEN expression in ERG-negative prostate cancer predicts secondary therapies and leads to shorter disease-specific survival time after radical prostatectomy

    Lahdensuo, K., Erickson, A., Saarinen, I., Seikkula, H., Lundin, J., Lundin, M., Nordling, S., Butzow, A., Vasarainen, H., Bostrom, P. J., Taimen, P., Rannikko, A. & Mirtti, T. Dec 2016 In : Modern Pathology. 29, 12, p. 1565-1574 10 p.

    Research output: Scientific - peer-reviewArticle

Previous 1 2 3 4 5 6 Next